Project Grant HT9425261E022
Award Date 4/1/26
Completion Date 3/31/29
Dollars Obligated $990K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
- The Department of Defense's Defense Health Agency has awarded a $866,250 Project Grant to the Trustees of Boston University, doing business as the Boston University Medical Campus, under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2024, will fund a research project titled "TARGETING TRANSCRIPTIONAL NETWORKS DIRECTING IMMUNE EVASION IN PROGRESSIVE BRONCHIAL PREMALIGNANT LESIONS" through June 30, 2027. As a leading private research...
- Federal Project Grant Award Summary Boston University Medical Campus received a $6.52 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the project "Brief Caspase Inhibition for Neuroprotection in Pediatric Cardiac Surgery," with an award date of August 1, 2025, and a performance period extending through July 31, 2029. This four-year research initiative will be conducted at the awardee's facility...
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $330,000 project grant to Trustees of Boston University, doing business as the Boston University Medical Campus. The grant, awarded on March 15, 2024, will fund research to enhance lymphatic function using transplanted muscle cells after bacterial infection. The research aims to improve medical care for military service members, veterans, and their families. Boston University, a leading...
- This federal Project Grant award, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), will support research at Trustees of Boston University's Medical Campus to investigate the role of circular RNA in host defense against bacterial sepsis and lung injury. The $1,635,000 award, effective April 1, 2025 through March 31, 2029, will fund advanced biomedical research aimed at transforming healthcare for military personnel and the broader...
- Federal Grant Award Summary The Defense Health Agency awarded Massachusetts General Hospital a $382,381 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025 through August 31, 2028. The award supports research into "Genetic Immunodetection and Treatment of VCA Rejection," focusing on advancing biomedical solutions relevant to military healthcare needs. This three-year initiative leverages MGH's Research Management...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Massachusetts General Hospital $992,302 through the Military Medical Research and Development program (CFDA 12.420) on September 15, 2025, to support a three-year research project titled "Targeting MHCII Ubiquitination to Induce Immune Regulation in Vascularized Composite Tissue Transplantation." The project, which concludes on September 14, 2028, focuses on advancing biomedical research aimed at transforming...
- Federal Grant Award Summary The Defense Health Agency awarded Massachusetts General Hospital a $198,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective May 1, 2025, through April 30, 2026. The award supports research titled "Precision Medicine for Non Small Cell Lung Cancer Brain Metastases: Noninvasive Detection of Targetable Mutations Using Radiosurgery," conducted through MGH's Research Management Division in Boston, Massachusetts....
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. (DFCI) received a $1.424 million Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. The award supports research titled "Expanding the Targetable Tumor Antigen Repertoire of Renal Cell Carcinoma," conducted at DFCI's Boston, Massachusetts facility. This research initiative aims to identify and...
- Federal Grant Award Summary Boston University received a $300,000 Project Grant award from the U.S. Army Research Development and Engineering Command under the Basic Scientific Research program (CFDA 12.431) on September 15, 2025, with a completion date of September 14, 2028. The research addresses the integration of non-Hermitian physics with nonlinear optics to enhance infrared (IR) photon absorption at the nanoscale. Specifically, the award funds the engineering of spectral singularities in...
- Federal Project Grant Award Summary The University of Washington received a $1.49 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop biomaterial strategies that improve the specificity and efficacy of Chimeric Antigen Receptor T (CAR-T) cell therapy for breast cancer treatment. The award, effective April 1, 2026, through March 31, 2029, supports advanced biomedical research aimed at enhancing immunotherapy...